The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

Mon, 30th Sep 2019 09:55

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

BARCLAYS CUTS WHITBREAD TO 'EQUAL WEIGHT' ('OVERWEIGHT') - PRICE TARGET 4350 (4700) PENCE

----------

BARCLAYS RAISES SSE TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - PRICE TARGET 1300 (1000) PENCE

----------

BERENBERG CUTS BT GROUP PRICE TARGET TO 220 (240) PENCE - 'HOLD'

----------

CREDIT SUISSE CUTS BHP GROUP PRICE TARGET TO 1850 (1930) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE CUTS GLENCORE PRICE TARGET TO 275 (300) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE CUTS ANGLO AMERICAN TARGET TO 2600 (2710) PENCE - 'OUTPERFORM'

----------

UBS CUTS PRUDENTIAL PRICE TARGET TO 1900 (2000) PENCE - 'BUY'

----------

UBS CUTS PEARSON PRICE TARGET TO 900 (1000) PENCE - 'BUY'

----------

JPMORGAN CUTS PEARSON PRICE TARGET TO 1010 (1115) PENCE - 'OVERWEIGHT'

----------

EXANE BNP INITIATES HISCOX WITH 'OUTPERFORM' - PRICE TARGET 1825 PENCE

----------

FTSE 250

----------

DEUTSCHE BANK RAISES PENNON GROUP TO 'BUY' ('HOLD') - PRICE TARGET 880 (780) PENCE

----------

BERENBERG CUTS MARKS & SPENCER PRICE TARGET TO 160 (250) PENCE - 'SELL'

----------

JEFFERIES CUTS CLOSE BROTHERS PRICE TARGET TO 1520 (1570) PENCE - 'HOLD'

----------

RBC RAISES HOMESERVE TO 'OUTPERFORM' (SECTOR PERFORM) - TARGET 1500 (800) PENCE

----------

JEFFERIES CUTS TRAVIS PERKINS PRICE TARGET TO 1400 (1457) PENCE - 'HOLD'

----------

EXANE BNP INITIATES LANCASHIRE HOLDINGS WITH 'OUTPERFORM' - TARGET 800 PENCE

----------

EXANE BNP INITIATES BEAZLEY WITH 'NEUTRAL' - TARGET 650 PENCE

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM INITIATES OXFORD BIOMEDICA WITH 'BUY' - PRICE TARGET 810 PENCE

----------

LIBERUM INITIATES CLINIGEN WITH 'HOLD' - TARGET 1000 PENCE

----------

LIBERUM INITIATES ABCAM WITH 'HOLD' - TARGET 1230 PENCE

----------

JEFFERIES RAISES GAMMA COMMUNICATIONS PRICE TARGET TO 1320 (1270) PENCE - 'BUY'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

Read more
23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

Read more
16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

Read more
9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

IN BRIEF: Clinigen signs global distribution deal for Qinlock

Read more
8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

Read more
17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

Triton increases takeover bid for Clinigen to GBP1.3 billion

Read more
17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

Read more
12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

Read more
12 Jan 2022 11:13

Clinigen holds earnings growth guidance after solid first half

Clinigen holds earnings growth guidance after solid first half

Read more
11 Jan 2022 14:59

CORRECT: UK shareholder meetings calendar - next 7 days

CORRECT: UK shareholder meetings calendar - next 7 days

Read more
11 Jan 2022 14:46

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Dec 2021 15:55

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
8 Dec 2021 11:56

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.